Carcinomatous meningitis in non-small-cell lung cancer: response to high-dose erlotinib

J Clin Oncol. 2009 Aug 1;27(22):e31-2. doi: 10.1200/JCO.2008.21.0963. Epub 2009 Jun 1.
No abstract available

Publication types

  • Case Reports

MeSH terms

  • Antineoplastic Combined Chemotherapy Protocols / administration & dosage
  • Biopsy, Needle
  • Carcinoma, Non-Small-Cell Lung / drug therapy*
  • Carcinoma, Non-Small-Cell Lung / pathology
  • Carcinoma, Non-Small-Cell Lung / secondary*
  • Disease Progression
  • Dose-Response Relationship, Drug
  • Erlotinib Hydrochloride
  • Fatal Outcome
  • Female
  • Humans
  • Immunohistochemistry
  • Lung Neoplasms / drug therapy*
  • Lung Neoplasms / pathology*
  • Magnetic Resonance Imaging
  • Meningeal Neoplasms / complications
  • Meningeal Neoplasms / diagnosis
  • Meningeal Neoplasms / drug therapy
  • Meningeal Neoplasms / secondary*
  • Meningitis / drug therapy
  • Meningitis / etiology
  • Meningitis / pathology
  • Middle Aged
  • Neoplasm Invasiveness / pathology
  • Neoplasm Recurrence, Local / drug therapy
  • Neoplasm Recurrence, Local / pathology
  • Neoplasm Staging
  • Quinazolines / administration & dosage*
  • Risk Assessment
  • Tomography, X-Ray Computed

Substances

  • Quinazolines
  • Erlotinib Hydrochloride